Molecular and Cellular Biochemistry

, Volume 259, Issue 1, pp 197-209

First online:

Myosin phosphatase: Structure, regulation and function

  • Masaaki ItoAffiliated withFirst Department of Internal Medicine, Mie University School of Medicine
  • , Takeshi NakanoAffiliated withFirst Department of Internal Medicine, Mie University School of Medicine
  • , Ferenc ErdődiAffiliated withDepartment of Medical Chemistry, Medical and Health Science Center, University of Debrecen
  • , David J. HartshorneAffiliated withMuscle Biology Group, University of Arizona

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Phosphorylation of myosin II plays an important role in many cell functions, including smooth muscle contraction. The level of myosin II phosphorylation is determined by activities of myosin light chain kinase and myosin phosphatase (MP). MP is composed of 3 subunits: a catalytic subunit of type 1 phosphatase, PP1c; a targeting subunit, termed myosin phosphatase target subunit, MYPT; and a smaller subunit, M20, of unknown function. Most of the properties of MP are due to MYPT and include binding of PP1c and substrate. Other interactions are discussed. A recent discovery is the existence of an MYPT family and members include, MYPT1, MYPT2, MBS85, MYPT3 and TIMAP. Characteristics of each are outlined. An important discovery was that the activity of MP could be regulated and both activation and inhibition were reported. Activation occurs in response to elevated cyclic nucleotide levels and various mechanisms are presented. Inhibition of MP is a major component of Ca2+-sensitization in smooth muscle and various molecular mechanisms are discussed. Two mechanisms are cited frequently: (1) Phosphorylation of an inhibitory site on MYPT1, Thr696 (human isoform) and resulting inhibition of PP1c activity. Several kinases can phosphorylate Thr696, including Rho-kinase that serves an important role in smooth muscle function; and (2) Inhibition of MP by the protein kinase C-potentiated inhibitor protein of 17 kDa (CPI-17). Examples where these mechanisms are implicated in smooth muscle function are presented. The critical role of RhoA/Rho-kinase signaling in various systems is discussed, in particular those vascular smooth muscle disorders involving hypercontractility.

myosin phosphatase type 1 phosphatase MYPT1 Rho Rho-kinase CPI-17 smooth muscle Ca2+ sensitization cGMP-dependent protein kinase